News

The agreement is for the development of a marketed protein to be delivered using Flamel’s Medusa technology. Flamel is also receiving additional revenues from Wyeth for work being

The goal of the collaboration is to develop a series of genetic tests that will help physicians better understand an individual’s inherited resistance to weight loss and, more

The agreement will begin on October 1, 2008 and run for a three-year term. The agreement is said to offer Amerinet’s membership competitive market pricing, and access to

The trial, called Oracle MS will evaluate the safety and efficacy of two dosage regimens of cladribine tablets versus placebo in the treatment of patients who have experienced

The combination of this gene with Amsterdam Molecular Therapeutics’s (AMT) proprietary adeno-associated virus gene therapy platform could potentially allow the development of an effective, long-term treatment for this

Both Novo Nordisk and BioGeneriX are existing collaborative partners of Neose. Certain intellectual property rights, including those related to producing glycolipids, have been retained by Neose for future

Karin Hamberg, who is currently executive vice president of drug delivery research and alliance & project management, will assume responsibility for clinical, regulatory, and medical affairs undertaking Dr

The new results from the Crystel study show that after taking Enbrel for a year, either as continuous or intermittent therapy, patients experienced significant skin clearance as well

Mr Lechleiter, president and CEO of Lilly, will succeed outgoing chairman Sidney Taurel, who had previously announced his retirement from the company and the board, effective December 31,